Suarez-Almazor, Maria E.

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

Brahmer, J. R., Lacchetti, C., Schneider, B. J., Atkins, M. B., Brassil, K. J., Caterino, J. M., Chau, I., Ernstoff, M. S., Gardner, J. M., Ginex, P., et al. (2018) · Journal of Clinical Oncology

Cancer Immunotherapy and BiomarkersPharmacovigilance and Adverse Drug Reactions

Cited by 3,713

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group

on behalf of the Society for Immunotherapy of Cancer Toxicity Management Working Group, Puzanov, I., Diab, A., Abdallah, K., Bingham, C. O., Brogdon, C., Dadu, R., Hamad, L., Kim, S., Lacouture, M. E., et al. (2017) · Journal for ImmunoTherapy of Cancer

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 1,992

Use of Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Autoimmune Disease: A Systematic Review

Abdel-Wahab, N., Shah, M., Lopez-Olivo, M. A., & Suarez-Almazor, M. E. (2018) · Annals of Internal Medicine

Cancer Immunotherapy and BiomarkersPharmacovigilance and Adverse Drug Reactions

Cited by 487

Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature

Abdel-Wahab, N., Safa, H., Abudayyeh, A., Johnson, D. H., Trinh, V. A., Zobniw, C. M., Lin, H., Wong, M. K., Abdelrahim, M., Gaber, A. O., et al. (2019) · Journal for ImmunoTherapy of Cancer

Cancer Immunotherapy and BiomarkersTransplantation: Methods and Outcomes

Cited by 294

Comparative Effectiveness of Goal Setting in Diabetes Mellitus Group Clinics: Randomized Clinical Trial

Naik, A. D., Palmer, N., Petersen, N. J., Street, R. L., Rao, R., Suarez-Almazor, M., & Haidet, P. (2011) · Archives of Internal Medicine

Diabetes Management and EducationDiabetes Management and Research

Cited by 176

Successful treatment of arthritis induced by checkpoint inhibitors with tocilizumab: a case series

Kim, S. T., Tayar, J., Trinh, V. A., Suarez-Almazor, M., Garcia, S., Hwu, P., Johnson, D. H., Uemura, M., & Diab, A. (2017) · Annals of the Rheumatic Diseases

Cancer Immunotherapy and BiomarkersRheumatoid Arthritis Research and Therapies

Cited by 170

The Prevalence of Peripheral Arterial Disease in a Racially Diverse Population

Collins, T. C., Petersen, N. J., Suarez-Almazor, M., & Ashton, C. M. (2003) · Archives of Internal Medicine

Peripheral Artery Disease ManagementVascular Procedures and Complications

Cited by 157

Radiomics to predict immunotherapy-induced pneumonitis: proof of concept

Colen, R. R., Fujii, T., Bilen, M. A., Kotrotsou, A., Abrol, S., Hess, K. R., Hajjar, J., Suarez-Almazor, M. E., Alshawa, A., Hong, D. S., et al. (2018) · Investigational New Drugs

Radiomics and Machine Learning in Medical ImagingCancer Immunotherapy and Biomarkers

Cited by 120

Marine Oil Supplements for Arthritis Pain: A Systematic Review and Meta-Analysis of Randomized Trials

Senftleber, N., Nielsen, S., Andersen, J., Bliddal, H., Tarp, S., Lauritzen, L., Furst, D., Suarez-Almazor, M., Lyddiatt, A., & Christensen, R. (2017) · Nutrients

Fatty Acid Research and HealthRheumatoid Arthritis Research and Therapies

Cited by 114

Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus

Achaval, S. D., & Suarez-Almazor, M. E. (2010) · International Journal of Clinical Rheumatology

Medication Adherence and ComplianceRheumatoid Arthritis Research and Therapies

Cited by 90

Diabetes Mellitus, Smoking, and the Risk for Asymptomatic Peripheral Arterial Disease: Whom Should We Screen?

Eason, S. L., Petersen, N. J., Suarez-Almazor, M., Davis, B., & Collins, T. C. (2005) · The Journal of the American Board of Family Medicine

Peripheral Artery Disease ManagementDiabetic Foot Ulcer Assessment and Management

Cited by 55

Immune-related adverse events and survival in elderly patients with melanoma treated with ipilimumab.

Mian, I., Yang, M., Zhao, H., Shah, M., Diab, A., Shannon, V., Patel, A., Amaria, R. N., Giordano, S. H., & Suarez-Almazor, M. E. (2016) · Journal of Clinical Oncology

Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management

Cited by 25

The outcome of checkpoint inhibitor therapy in patients with cancer and solid organ transplant: A systematic review of the literature.

Hassan, N. A., Abudayyeh, A., Shah, M., Johnson, D. H., Suarez-Almazor, M. E., & Diab, A. (2018) · Journal of Clinical Oncology

Cancer Immunotherapy and BiomarkersTransplantation: Methods and Outcomes

Cited by 9